%0 Journal Article
%T 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白抑制强直性脊柱炎趋化因子CXCL16及其受体CXCR6的表达<br>Expression of chemokine CXCL16 and its receptor CXCR6 can be suppressed by rcombinant human TNF receptor α Ⅱ-Ig fusion protein in ankylosing spondylitis
%A 张培艺
%A 周淑芬
%A 王梅英
%A 雷振华
%A 翁俊雄
%A 田野
%A 彭鑫
%A 傅碧玲
%A 邓柳霞
%A 邹世海
%A 郭成山&lt
%A br&gt
%A ZHANG Peiyi
%A ZHOU Shufen
%A WANG Meiying
%A LEI Zhenhua
%A WENG Junxiong
%A TIAN Ye
%A PENG Xin
%A FU Biling
%A DENG Liuxia
%A ZOU Shihai
%A GUO Chengshan
%J 山东大学学报（医学版）
%D 2015
%R 10.6040/j.issn.1671-7554.0.2015.253
%K 强直性脊柱炎
%K 趋化因子受体CXCR6
%K 核因子-&kappa
%K 趋化因子CXCL16
%K B受体活化因子配体
%K 骨保护素
%K &lt
%K br&gt
%K Osteoprotegerin
%K Ankylosing spondylitis
%K Chemokine CXCL16
%K Chemokine receptor CXCR6
%K Receptor activator of nuclear factor κB-ligand
%U http://yxbwk.njournal.sdu.edu.cn/CN/10.6040/j.issn.1671-7554.0.2015.253